Director Commercial Training

How will your role help us transform hope into reality

The Director Commercial Training will be responsible for the strategy and of commercial Training. The scope of commercial training includes both field sales and nonsales field roles within the US Commercial business for AYVAKIT our commercially approved therapy. This individual will use cross functional collaboration influence and decisionmaking authority to develop the strategy and tactically execute in a fastpaced environment. The Director Commercial Training will report to the Senior Director Commercial Operations and serve as a key member of the extended field leadership team.

What will you do

• Tactical Training : You will have an opportunity to identify skill and capability gaps create training content and execute with cross functional partners to elevate field impact.
• Strategic Leadership:You will be responsible for setting the vision and aligning learning initiatives with broader business priorities to enable growth. The expectation is to proactively identify and solve complex challenges that impact the direction of the business.
• CrossFunctional Influence:You will engage with commercial leaders and stakeholders across various departments (sales marketing market access precision medicine market access & HR) to drive alignment and foster collaboration to develop and implement a field training strategy to support a growing commercial franchise. You will routinely negotiate and influence opinions of others to help move the business forward.
• DecisionMaking Authority:You will lead enterprisewide strategies manage budgets and make highimpact decisions to drive organizational and commercial success directly with our field organization. You will have accountability for final decisions on training strategy and while carefully considering perspectives of leadership and cross functional partners.
• Subject Matter Expert: In addition to being a commercial training subject matter expert you will become a subject matter expert in Systemic Mastocytosis and AYVAKIT with the ability to lead from the front of the room with your knowledge skill coaching and demonstration capability. The organization will lean on you for broader external commercial training awareness and benchmarking for building out capability needed for continued commercial growth.
• Engage with Field Team Members: You will engage with field team members 15 of your time to gain a deeper understanding of realworld customer interactions to inform training plan strategy and . Your efforts and expertise will be recognized as a functional authority for commercial training across the organization with the ability integrate expertise across field & HQ functions.

What minimum qualifications do we require

• 8 years of relevant commercial experience in biotech/pharma with a minimum of 4 years of experience in commercial training or related functions.
• Bachelors degree required

What additional qualifications will make you a stronger candidate

• MBA or other advanced degree preferred.
• Demonstrated ability to operate with high degree of ownership and strong in a fastpaced highgrowth environment.
• Strong authentic relationship builder cross functionally to create meaningful proactive twoway dialog around commercial training strategy and .
• Experience in specialty markets particularly oncology Allergy/Immunology or rare diseases preferred.
• Demonstrated success with project management and tactical of training plans.
• Ability to influence without authority and develop relationships with fieldbased teams.
• Comfortable with ambiguity; can drive towards implementation in a fastpaced and evolving environment.
• Highly collaborative; can comfortably work with a variety of colleagues and stakeholders to gain alignment.
• Relentlessly externally focused; keeps the patient at the center when making decisions.
• Excellent written and oral communication skills; comfortable delivering presentations to a wide range of stakeholders.
• Commitment to our Core Values: Patients First Thoughtfulness Urgency Trust Optimism.

Why Blueprint

At Blueprint Medicines we achieve impactful results because of our global crew of compassionate innovators the Blue Crew. Through authentic relationships and our collective entrepreneurial spirit and action we are each empowered to take ownership and execute with strategic prioritization. We put trust in our people to break through norms and conventions using their individual strengths and insights which drives our success.

This is the place where the extraordinary becomes reality and you could be part of it.

Patients are waiting. Are you ready to make the leap

Equity Diversity Inclusion and Affirmative Action

At Blueprint Medicines we foster a culture of equity diversity and inclusion. A proud Equal Employment Opportunity and Affirmative Action employer we consider all qualified applicants without regard to race color sex gender identity or expression sexual orientation age religion national origin ancestry ethnicity disability veteran status genetic information or any other characteristic protected under applicable law. We are also an EVerify Employer. We will make reasonable accommodations absent undue hardship for qualified individuals with known disabilities. If you are an individual with a disability in need of an accommodation with the application or recruiting process please reach out to

For more information please see ourEEOAA Policy Statement the EVerify Participation Poster the Right to Work Poster and/or theEEO Know Your Rights Poster as well as ourPay Transparency Statement.

Blueprint Medicines is a global fully integrated biopharmaceutical company that invents lifechanging medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines including bringing our medicine to patients with systemic mastocytosis (SM) in the U.S. and Europe. Leveraging our established research development and commercial capability and infrastructure we now aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases including SM and chronic urticaria breast cancer and other solid tumors.